Does semaglutide help with Alzheimer's disease?

The evidence says no, at least so far. The evoke and evoke plus studies, both large final-stage studies, tested semaglutide in 3,808 people for Alzheimer's disease. It did not slow the disease on the main thing they measured. That is a real, finished result, not a lack of research. Semaglutide still has strong evidence in diabetes, obesity, and lowering heart risk, and the Alzheimer's result does not change that.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.